Bedel Financial Consulting, Inc. - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 54 filers reported holding CTI BIOPHARMA CORP in Q2 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
Bedel Financial Consulting, Inc. ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2022$0–100.0%0.00%–
Q4 2021$0–100.0%0.00%–
Q3 2021$0–100.0%0.00%–
Q2 2021$0–10–0.00%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q2 2021.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders